Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Insys Therapeutics, Inc. (INSY)

« Back to company index

INSY Chatter Timeline

Stock Ticker for INSY

Most Active Tweeters for INSY

UserTweets
@OfficialHemp 37
@CannabizMarkets 18
@VegasTours 11
@myrollingstocks 7
@Escells 7

Recent Tweets for INSY

channelingstock @channelingstock
Do you thing the movement in $INSY will continue https://t.co/o2im4KnZRk
July 19th 2018, 5:07pm
myrollingstocks @myrollingstocks
Do you thing the movement in $INSY will continue https://t.co/nRETW0vIgZ
July 19th 2018, 5:07pm
MC_OptionTrades @MC_OptionTrades
$INSY Option Markets Imply a Hard to Short Rate with the 16-Nov-18 8 Synthetic Long(8.05) at a Discount to Spot(8.3… https://t.co/QbWpRn9sex
July 19th 2018, 4:07pm
Soopy9 @Soopy9
$INSY strong in the Cannablitz Storm
July 19th 2018, 2:07pm
Escells @Escells
RT @Escells: $INSY Epinephrine Nasal Spray in Development for Treatment of Anaphylaxis Shows Promise as Potential Alternative to Int…
July 19th 2018, 1:07pm
Escells @Escells
$INSY Epinephrine Nasal Spray in Development for Treatment of Anaphylaxis Shows Promise as Potential Alterna… https://t.co/49i70jUqxj
July 19th 2018, 1:07pm
VegasTours @VegasTours
RT @OfficialHemp: $INSY Insys Says Proprietary Intranasal Epinephrine Formulation Achieves Results Similar to Mylan's Epipen https://t.co/r…
July 19th 2018, 12:07pm
VegasTours @VegasTours
Insys Therapeutics Inc $INSY +1.46% has a July 28 FDA date and is set to receive the verdict on the company's s… https://t.co/TUXnLwb8dB
July 19th 2018, 12:07pm
VegasTours @VegasTours
$INSY Epinephrine Nasal Spray in Development for Treatment of Anaphylaxis Shows Promise as Potential Alter… https://t.co/70R3Mgfy4N
July 19th 2018, 12:07pm
OfficialHemp @OfficialHemp
RT @OfficialHemp: Cannabis Biotech Stock > $INSY Insys Says Proprietary Intranasal Epinephrine Formulation Achieves Results Similar to…
July 19th 2018, 11:07am
OfficialHemp @OfficialHemp
Cannabis Biotech Stock > $INSY Insys Says Proprietary Intranasal Epinephrine Formulation Achieves Results Simila… https://t.co/WHO30bLYmw
July 19th 2018, 10:07am
OfficialHemp @OfficialHemp
$INSY Insys Says Proprietary Intranasal Epinephrine Formulation Achieves Results Similar to Mylan's Epipen… https://t.co/L0bkHgWrRY
July 19th 2018, 9:07am
S20ll @S20ll
$INSY looks like a trade for me today if volume permits Good Morning #traders !
July 19th 2018, 9:07am
CannabizMarkets @CannabizMarkets
RT @CannabizMarkets: INSYS Therapeutics, Inc. Nasdaq $INSY manufacturer of SYNDROS® a cannabinoid medicine and is the first and only FDA ap…
July 19th 2018, 2:07am
CannabizMarkets @CannabizMarkets
RT @CannabizMarkets: INSYS Therapeutics, Inc. Nasdaq $INSY manufacturer of SYNDROS® a cannabinoid medicine and is the first and only FDA a…
July 19th 2018, 2:07am
CannabizMarkets @CannabizMarkets
RT @CannabizMarkets: INSYS Therapeutics, Inc. Nasdaq $INSY manufacturer of SYNDROS® a cannabinoid medicine and is the first and only FDA…
July 19th 2018, 2:07am
CannabizMarkets @CannabizMarkets
RT @CannabizMarkets: INSYS Therapeutics, Inc. Nasdaq $INSY manufacturer of SYNDROS® a cannabinoid medicine and is the first and only FDA…
July 19th 2018, 2:07am
CannabizMarkets @CannabizMarkets
RT @CannabizMarkets: $INSY 8.11 [+]up tick 0.38 (4.92%) I knew this was gonna fly. Just starting. I had to get ri…
July 19th 2018, 2:07am
TheUnicornBay @TheUnicornBay
Btw, Estimated #Earnings Per Share for $INSY is $-0.12 it's -1.55% of the current price https://t.co/OusvjRij0m
July 18th 2018, 11:07pm
CannabizMarkets @CannabizMarkets
RT @Escells: Allergy News! Insys Therapeutics $INSY its 'epinephrine nasal spray showed promise in an early clinical trial as a poten…
July 18th 2018, 10:07pm
CannabizMarkets @CannabizMarkets
RT @Escells: Allergy Sufferers News $INSY $8's Epinephrine Nasal Spray in Development for Treatment of Anaphylaxis Shows Promise as Pote…
July 18th 2018, 10:07pm
CannabizMarkets @CannabizMarkets
RT @TheMarketsDaily: Zacks: Brokerages Anticipate Insys Therapeutics Inc $INSY Will Post Quarterly Sales of $26.67 Million https://t.co/2TA…
July 18th 2018, 10:07pm
TheMarketsDaily @TheMarketsDaily
Zacks: Brokerages Anticipate Insys Therapeutics Inc $INSY Will Post Quarterly Sales of $26.67 Million https://t.co/2TArhUH28x
July 18th 2018, 8:07pm
1MinuteStock @1MinuteStock
Wondering about risks of $INSY? The 21-day volatility is 13.29% https://t.co/jiYgNXSNSh
July 18th 2018, 8:07pm
dispatchtribune @dispatchtribune
Insys Therapeutics $INSY Stock Price Up 5.4% https://t.co/CQm3GWcTnC
July 18th 2018, 8:07pm
EnterpriseLeade @EnterpriseLeade
Insys Therapeutics $INSY Trading Up 5.4% https://t.co/X4795rlLda
July 18th 2018, 8:07pm
ChartMill @ChartMill
$INSY: The short term trend is positive, while the long term trend is neutral. So this is evolving in the right ...… https://t.co/3AgKuk9Qo6
July 18th 2018, 5:07pm
luzgarciacalde1 @luzgarciacalde1
RT @myrollingstocks: Do you thing the movement in $INSY will continue https://t.co/YHSY8J67eM
July 18th 2018, 5:07pm
myrollingstocks @myrollingstocks
Do you thing the movement in $INSY will continue https://t.co/YHSY8J67eM
July 18th 2018, 5:07pm
bibeypost_stock @bibeypost_stock
INSYS Therapeutics, Inc. $INSY Analysts See $-0.25 EPS - https://t.co/fephyVSSEA
July 18th 2018, 4:07pm
Fanob_stock @Fanob_stock
INSYS Therapeutics, Inc. $INSY EPS Estimated At $-0.25 https://t.co/tI2p2SY0GW
July 18th 2018, 4:07pm
nutsqueezer5000 @nutsqueezer5000
$INSY U.S. judge questions scope of indictment against Insys founder https://t.co/zJpwKFulfG
July 18th 2018, 3:07pm
CannabizMarkets @CannabizMarkets
RT @StockzResearch: INSYS Therapeutics, Inc. Nasdaq $INSY manufacturer of SYNDROS® a cannabinoid medicine and is the first and only FDA app…
July 18th 2018, 3:07pm
CannabizMarkets @CannabizMarkets
RT @StockzResearch: INSYS Therapeutics, Inc. Nasdaq $INSY manufacturer of SYNDROS® a cannabinoid medicine and is the first and only FDA ap…
July 18th 2018, 3:07pm
CannabizMarkets @CannabizMarkets
RT @StockzResearch: INSYS Therapeutics, Inc. Nasdaq $INSY manufacturer of SYNDROS® a cannabinoid medicine and is the first and only FDA a…
July 18th 2018, 3:07pm
CannabizMarkets @CannabizMarkets
RT @StockzResearch: INSYS Therapeutics, Inc. Nasdaq $INSY manufacturer of SYNDROS® a cannabinoid medicine and is the first and only FDA…
July 18th 2018, 3:07pm
CannabizMarkets @CannabizMarkets
RT @StockzResearch: $INSY 8.11 [+]up tick 0.38 (4.92%) I knew this was gonna fly. Just starting. I had to get rid…
July 18th 2018, 3:07pm
SwingTradeBot @SwingTradeBot
Recent $INSY technical alerts: MACD Bullish Signal Line Cross plus 2 more alerts... https://t.co/AZHQavoE11
July 18th 2018, 1:07pm
CannabizMarkets @CannabizMarkets
$INSY 8.11 [+]up tick 0.38 (4.92%) I knew this was gonna fly. Just starting. I had to get… https://t.co/2GKQmB5M5P
July 18th 2018, 1:07pm
OfficialHemp @OfficialHemp
Cannabis Healthcare Biotech @ #1 Syndros $INSY is the first and only FDA approved dronabinol solution for oral use.… https://t.co/W65JBycvMZ
July 18th 2018, 12:07pm
CannabizMarkets @CannabizMarkets
INSYS Therapeutics, Inc. Nasdaq $INSY manufacturer of SYNDROS® a cannabinoid medicine and is the first and only… https://t.co/RDP2bk5ptY
July 18th 2018, 12:07pm
CannabizMarkets @CannabizMarkets
INSYS Therapeutics, Inc. Nasdaq $INSY manufacturer of SYNDROS® a cannabinoid medicine and is the first and only F… https://t.co/TQY3zDIlq3
July 18th 2018, 12:07pm
CannabizMarkets @CannabizMarkets
INSYS Therapeutics, Inc. Nasdaq $INSY manufacturer of SYNDROS® a cannabinoid medicine and is the first and only FD… https://t.co/yKE5QDmdmh
July 18th 2018, 12:07pm
CannabizMarkets @CannabizMarkets
INSYS Therapeutics, Inc. Nasdaq $INSY manufacturer of SYNDROS® a cannabinoid medicine and is the first and only FDA… https://t.co/lPyYFxpIq3
July 18th 2018, 12:07pm
MC_OptionTrades @MC_OptionTrades
$INSY Option Markets Imply a Hard to Short Rate with the 16-Nov-18 8 Synthetic Long(7.80) at a Discount to Spot(8.1… https://t.co/NXAElbm18t
July 18th 2018, 12:07pm
Escells @Escells
RT @Escells: $INSY Epinephrine Nasal Spray in Development for Treatment of Anaphylaxis Shows Promise as Potential Alternative to Intra…
July 18th 2018, 12:07pm
Escells @Escells
RT @Escells: $INSY Undervalued Cannabis Pipeline @ https://t.co/jq4uqZJ6O9 // $CRON #CANNABIS #WEED #MJ #WEEDSTOCKS #POTSTOCKS #MARIJ…
July 18th 2018, 12:07pm
Escells @Escells
Allergy News! Insys Therapeutics $INSY its 'epinephrine nasal spray showed promise in an early clinical trial… https://t.co/fRUHet3tcA
July 18th 2018, 12:07pm
Escells @Escells
$INSY Undervalued Cannabis Pipeline @ https://t.co/jq4uqZJ6O9 // $CRON #CANNABIS #WEED #MJ #WEEDSTOCKS… https://t.co/djVwL1SGdx
July 18th 2018, 11:07am
Escells @Escells
Allergy Sufferers News $INSY $8's Epinephrine Nasal Spray in Development for Treatment of Anaphylaxis Shows Promi… https://t.co/3LwMEeWdpS
July 18th 2018, 11:07am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.